1 Product identity
Ingredient risk
Contains restricted ingredients
აშვაგანდას კაფსულები
BrandHerbalhealing→მამაკაცის ჰორმონალური ბალანსი და ლიბიდოს მხარდაჭერა 1 ingredients 1 banned Source: herbalhealing.ge ↗DSLD entry: 2026-06-02
2 Ingredients (1)
IngredientGroupSafety
Ingredient details from the manufacturer listing. View product at herbalhealing.ge →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
5 Data source
DSLD ID900000031
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2026-06-02
6 More from Herbalhealing
View Herbalhealing Safety Scorecard → 24 products
C მაქსი (ამლა) კაფსულებიალოე ვერას კაფსულებიბრაჰმის კაფსულებიდარიჩინის და მიხაკის კაფსულებიიმუნო ლაიფიკალონჯი (შავი თესლი) კაფსულები7 Cite this page
Vancouver
Pkhakadze G. აშვაგანდას კაფსულები — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/%e1%83%90%e1%83%a8%e1%83%95%e1%83%90%e1%83%92%e1%83%90%e1%83%9c%e1%83%93%e1%83%90%e1%83%a1-%e1%83%99%e1%83%90%e1%83%a4%e1%83%a1%e1%83%a3%e1%83%9a%e1%83%94%e1%83%91%e1%83%98-900000031/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG